Search Browse Earnings

EXICURE, INC.

Nasdaq:XCUR

Pharmaceutical Preparations·CHICAGO, IL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

EXICURE, INC. — SlamSEC

Revenue

$0

-100.0% YoY

FY 2024

Adj. EBITDA

-$14.4M

FY 2024

Net Income

-$16.9M

FY 2024

EPS (Diluted)

-$10.55

FY 2024

Stock Price

$4.09

-1.7%

2026-03-09

52W Range

$3.10 – $15.91

P/E Ratio

-0.4x

Market Cap

$26.1M

Cash

$8.6M

FY 2023

Total Debt

$16.6M

FY 2021

Net Debt

$8.0M

FY 2021

Enterprise Value

$34.1M

Debt / EBITDA

-0.6x

FY 2024

EV / EBITDA

-2.4x

Employees

—